Debbie Rigby rounds up the latest in research news Cardiovascular risk assessment in women: which women are suited for menopausal hormone therapy? Individual risk assessment for atherosclerotic cardiovascular disease is important for safe menopausal hormone prescription. MHT is, in general, not recommended in women at high atherosclerotic cardiovascular diseases risk and after a prior cardiovascular
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.